Search research articles
Contact Us
Filters
Showing results (181-190 of 207) with videos related to
Page
of 21
Sort By:
Environmental Health Perspectives
|
August 13, 2013
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications
Honglei Chen, Edward A Burton, G Webster Ross, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Environmental Health Perspectives
|
January 24, 2009
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007
Jeff Bronstein, Paul Carvey, Honglei Chen, et al.
The Lancet. Neurology
|
June 21, 2017
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts
Ganqiang Liu, Joseph J Locascio, Jean-Christophe Corvol, et al.
Frontiers in Aging Neuroscience
|
November 2, 2020
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Andrea Sturchio, Luca Marsili, Joaquin A Vizcarra, et al.
Acta Neuropathologica
|
March 30, 2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang, Brit Mollenhauer, Christopher S Coffey, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Journal of Parkinson'S Disease
|
April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative
Richard K Wyse, Tom Isaacs, Roger A Barker, et al.
Parkinsonism & Related Disorders
|
October 23, 2016
Knowledge gaps and research recommendations for essential tremor
Franziska Hopfner, Dietrich Haubenberger, Wendy R Galpern, et al.
Neurology
|
February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Alberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 207) with videos related to
Sort By:
Page
of 21
Environmental Health Perspectives
|
August 13, 2013
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications
Honglei Chen, Edward A Burton, G Webster Ross, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Environmental Health Perspectives
|
January 24, 2009
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007
Jeff Bronstein, Paul Carvey, Honglei Chen, et al.
The Lancet. Neurology
|
June 21, 2017
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts
Ganqiang Liu, Joseph J Locascio, Jean-Christophe Corvol, et al.
Frontiers in Aging Neuroscience
|
November 2, 2020
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Andrea Sturchio, Luca Marsili, Joaquin A Vizcarra, et al.
Acta Neuropathologica
|
March 30, 2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang, Brit Mollenhauer, Christopher S Coffey, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Journal of Parkinson'S Disease
|
April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative
Richard K Wyse, Tom Isaacs, Roger A Barker, et al.
Parkinsonism & Related Disorders
|
October 23, 2016
Knowledge gaps and research recommendations for essential tremor
Franziska Hopfner, Dietrich Haubenberger, Wendy R Galpern, et al.
Neurology
|
February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Alberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
Page
of 21